Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Îòîðèíîëàðèíãîëîãèÿ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #61  
Ñòàðûé 11.03.2005, 08:53
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,282
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,625 ðàç(à) çà 32,699 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïñèõîëîãè÷åñêè ëþáîïûòíî, ÷òî çà ïîïûòêó ðàññêàçàòü êëèíè÷åñêîìó îðäèíàòîðó ïî ëîð- áîëåçíÿì, ÷òî äàëåêî íå âñåãäà äåòåé íàäî ëå÷èòü ýíåðãè÷íî, îñîáåííî ïðåïàðàòàìè, ýôôåêòèâíîñòü êîòîðûõ ñîìíèòåëüíà, à îòäàëåííûå ïîñëåäñòâèÿ ïðîñòî íå èçó÷àëèñü, ÷òî.áåñåäóÿ î ïðåäìåòå, õîðîøî áû èìåòü î íåì íåñêîëüêî áîëåå ïîëíóþ èíôîðìàöèþ,÷åì ñìóòíûå ñâåäåíèÿ, è õîðîøî áû ïðåäñòàâëÿòü, ÷òî áåñåäóþùèå ñ îðäèíàòîðîì ëþäè èìåþò íåêèé íåìàëûé ìåäèöèíñêèé è æèçåííûé îïûò, âñå áåñåäóþùèå áûëè ïðèãâîæäåíû þíîøåé ê ñòîëáó - îöåíèâàëè èõ ëè÷íîñòíûå êà÷åñòâà, õîòÿ ãîâîðèëè âðà÷è î ïîëèïðàãìàçèè è èñïîëüçîâàíèè ïðåïàðàòîâ ñîìíèòåëüíîé îòäàëåííîé áåçîïàñíîñòè è íåâíÿòíîé íåïîñðåäñòâåííîé ýôôåêòèâíîñòè ó äåòåé ìëàäøåãî âîçðàñòà...

Êîììåíòàðèè ê ñîîáùåíèþ:
Íàòàëüÿ Ï. îäîáðèë(à): Íå ó ñåáÿ æå â Ñèìôåðîïîëå îí áóäåò ðàçãîâàðèâàòü ñ ïðîôåññîðîì â ñòèëå "äà ïîøëè âû.."
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #62  
Ñòàðûé 11.03.2005, 09:16
Leopold Leopold âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 05.03.2005
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 11
Leopold ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåLeopold ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Red face

Èñêðåííå íàäåþñü, ÷òî ÂѨ, ÷òî âû âñå òóò ïèñàëè, óâàæàåìûå ìåäèêè, âûçâàíî èñêëþ÷èòåëüíî Âàøåé ëþáîâüþ ê ìåäèöèíå è æåëàíèåì íå íàâðåäèòü ïàöèåíòó.
Âñåì êòî ïîääåðæàë ìåíÿ - áîëüøîå ñïàñèáî. Äàæå ïðîñòîå îáùåíèå ñ ëþäüìè, èìåþùèìè îòíîøåíèå ê ìåäèöèíå, î÷åíü âàæíî äëÿ íàñ - ëþäåé, íå ðàçáèðàþùèõñÿ â ìåäèöèíå òàê, êàê âû, óâàæàåìûå ôîðóì÷àíå.

Êîììåíòàðèè ê ñîîáùåíèþ:
Aminazinka îäîáðèë(à): ïðèÿòíî âñòðåòèòü óìíîãî "ïîòðåáèòåëÿ", óìåþùåãî ôèëüòðîâàòü
yananshs îäîáðèë(à): Âû âñå ïðàâèëüíî ïîíÿëè. Çäîðîâüÿ Âàì è Âàøåìó ìàëûøó.
riltsov îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #63  
Ñòàðûé 11.03.2005, 14:40
Àâàòàð äëÿ Alon
Alon Alon âíå ôîðóìà
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 17.08.2004
Ãîðîä: Israel
Ñîîáùåíèé: 719
Alon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAlon ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñìîðê áåç ñîïëåé, ïîíîñ áåç êàëà.
Ëå÷åíèå áåç áîëüíîãî...

Êîììåíòàðèè ê ñîîáùåíèþ:
MedicKen îäîáðèë(à): Åñòü òàêîå äåëî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #64  
Ñòàðûé 11.03.2005, 23:46
Àâàòàð äëÿ MedicKen
MedicKen MedicKen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.03.2005
Ãîðîä: ÐÔ, Êðûì
Ñîîáùåíèé: 473
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
MedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàòàëüÿ Ï. - íå ïðèñâàèâàéòå ìíå, ïîæàëóéñòà, òî ÷åãî ÿ íå ãîâîðèë. Íå õîðîøî ýòî... ß àêòèâíî îòñòàèâàë ñâîþ ïîçèöèþ è íå áîëåå òîãî. Âàñ çàäåâàåò òî ÷òî ÿ ñïîðþ è îòñòàèâàþ ñâîå ìíåíèå? Òîãäà ýòî óæå Âàøè çàáëóæäåíèÿ.

Äëÿ Melnichenko - òîí Âàøèõ êîëëåã àãðåñèâåí.  òàêîé ñèòóàöèè êàê äîëæíî ïîñòóïàòü?! Ðóêè ââåðõ è âíèìàòü?! Äà, ÿ ìîëîä, è ïîýòîìó íåìíîãî íèãèëèñòè÷åí. Ìîæåò íåìíîãî ïàëêó ïåðåãíóë. Íî ÿ íå õîòåë íèêîìó âûðàçèòü ñâîå íåóâàæåíèå. Îïïîíåíòû òîæå íå âñåãäà áûëè ïðàâû.

Ïîëèïðàãìàçèÿ... ß æå íå ãîâîðþ ÷òî ýòî õîðîøî... À êàê ïîìî÷ü îäíèì, äâóìÿ ïðåïàðàòàìè ïðè áîëüøåé ÷àñòè ËÎÐ-ïàòîëîãèè? Íàó÷èòå!

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - ýòî ïî ñèíóïðåòó. Êàê íå äîâåðÿòü ëåãåíäàðíîé Ò.È. Ãàðàùåíêî? (êñòàòè, ñèíóïðåò ïðîøåë íà äíÿõ ïåðåðåãèñòðàöèþ â Óêðàèíå åãî òåïåðü ðåêîìåíäóþò ñ 2-õ ëåòíåãî âîçðàñòà, ðàíåå â àííîòàöèè ñ ãðóäíîãî âîçðàñòà ñìîòðèòå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] )

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - ýòî ïî óìêàëîðó, òîæå Ò.È. Ãàðàùåíêî â ñîàâòîðàõ

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - ïî èçîôðå, íå òàê ïðåçåíòàáåëüíî, íî â èíåòå íåò íè÷åãî ïîäõîäÿùåå - âñå îñòàëüíîå íà áóìàæíîì íîñèòåëå.

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] - ïî èììóíîìîäóëÿòîðàì ïðè ÎÐÂÈ (ñõåìó 5-òè ÿ ïðèâîäèë íå äëÿ ÎÐÂÈ, íî ïî èììóíîìîäóëÿòîðàì ïðè ÎÐÂÈ ÿ òîæå òåðïåë êðèòèêó).

Ïî ñîñóäîñóæèâàþùèì è ãèïîñåíñåáèëèçèðóþùèì îñîáûõ âîçðàæåíèé íå áûëî.

È ãäå ÿ áûë íå ïðàâ?! Óáðàòü îòåê èç íîñà ñîñóäîñóæèâàþùèìè - îáëåã÷èòü ñðàçó ñîñòîÿíèå ðåáåíêà (ðèíîñèíóñèòû ó äåòåé ìëàäøåãî âîçðàñòà - òÿæåëàÿ ïàòîëîãèÿ, â íåîíàòàëüíîì ïåðèîäå ðèíèò ìîæåò äàòü äàæå ñóäîðîãè), íàçíà÷èòü ñåêðåòîëèòèê - ñäåëàòü áîëåå æèäêèì âÿçêèé ñåêðåò, íàëàäèòü ìóêîöèëëèàðíûé òðàíñïîðò, óìêàëîð - ïðîòèâîâèðóñíîå è àíòèáàêòåðèàëüíîå äåéñòâèå, òàêæå ñëàáûé èììóíîìîäóëÿòîð, â ïîñëåäíåå âðåìÿ ãîâîðÿò î åãî ìóêîëèò÷åñêîì äåéñòâèè, â çàâèñèìîñòè îò ðèíîñêîïè÷åñêîé êàðòèíû èçîôðà - òîïè÷åñêèé àíòèáèîòèê, ãèïîñåíñåáèëèçèðóþùåå - àëëåðãè÷åñêèé êîìïîíåíò ïàòîãåíåçà ðèíîñèíóñèòîâ, àäåíîèäèòîâ åñòü è íà íåãî íóæíî âîçäåéñòâîâàòü. Ãèïîàëëåðãåííàÿ äèåòà - íó êàê áåç íåå?

Ýòî ïîëèïðàãìàçèÿ?! Ìîæåò áûòü... ß âîçäåéñòâóþ íà âñå çâåíüÿ ïàòîãåíåçà ïðè ýòîì íåò ïîòåíöèàëüíî ÿâíîãî ðèñêà íàâðåäèòü. ß æå íå ñ êíèæå÷êè ñõåìó ïðèâîæó. Äà îïûò íåáîëüøîé ó ìåíÿ - îêîëî 3-õ ëåò. Âñåãäà ñîâåòóþñü ñ êîëëåãàìè, ó íèõ îïûò çà ïëå÷àìè îãðîìíûé... Ýôôåêò îò òàêîãî ïîäõîäà åñòü è õîðîøèé... Äåëàþ óïîð íà ìåñòíîå ëå÷åíèå âñåãäà. Ñ÷èòàþ, ÷òî äîñòàòî÷íîå ìåñòíîå ëå÷åíèå è âðà÷åáíûå ìàíèïóëÿöèè (àíåìèçàöèÿ, Ïðîåòö è ò.ä.) â êîìïëåêñå ñ ôèçèîëå÷åíèåì äàäóò õîðîøèé ýôôåêò â ëüâèíîé äîëå íàøåé ïàòîëîãèè.

Íå íàäî ñ÷èòàòü ìåíÿ íåâåæäîé! Âñåãäà òðåïåòíî îòíîøóñü ê "íå íàâðåäè" è äóìàþ.

Äîêàçàòåëüíàÿ ìåäèöèíà... Èñïîëüçîâàòü ïðåïàðàòû íå èìåþùèå ñ Âàøåé òî÷êè çðåíèÿ "ñîìíèòåëüíîé îòäàëåííîé áåçîïàñíîñòè è íåâíÿòíîé íåïîñðåäñòâåííîé ýôôåêòèâíîñòè ó äåòåé ìëàäøåãî âîçðàñòà"? À ãäå ñïèñîê íàéòè? ß ÷èòàþ ñòàòüè - àâòîðèòåòíûå ñïåöèàëèñòû ðåêîìåíäóþò ýòè ïðåïàðàòû ê èñïîëüçîâàíèþ â êîìïëåêñíîé òåðàïèè... Ñîìíåâàòüñÿ íàäî âî âñåì, êîíå÷íî... Íî, êîãäà, íàïèñàííîå ñîâïàäàåò ñ ïîëó÷åííûì ýôôåêòîì íà ïðàêòèêå....

Òàê ÷òî ÿ íåìíîãî ðàñòåðÿí îò Âàøèõ çàÿâëåíèé.

Ïðèíîøó èçâåíåíèÿ çà íàñòîé÷èâîå (ìîæåò áûòü ãäå-òî óïðÿìîå) îòñòàèâàíèå ñâîåãî ìíåíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #65  
Ñòàðûé 12.03.2005, 10:33
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
ÎÏÛÒ ÏÐÈÌÅÍÅÍÈß ÏÐÅÏÀÐÀÒÀ “ÓÌÊÀËÎД
ÏÐÈ ÇÀÁÎËÅÂÀÍÈßÕ ËÎÐ-ÎÐÃÀÍÎÂ Ó ÄÅÒÅÉ

Ë. È. Èëüåíêî, À.Î. Ïàðôåíîâà, Ò. Í.Ñûðüåâà, Ò. È. Ãàðàùåíêî

Èç âåùåñòâ, ñîäåðæàùèõñÿ â Pelargonium reniforme/sidoides, áûëè èäåíòèôèöèðîâàíû, ïîìèìî ïðî÷åãî, êîôåéíàÿ êèñëîòà è ôëàâîíîë êâåðöèòèí. Ýòèì âåùåñòâàì ñâîéñòâåííà àíòèáàêòåðèàëüíàÿ àêòèâíîñòü (1,44 ã êîôåéíîé êèñëîòû ñîîòâåòñòâóåò 1 åäèíèöà ïåíèöèëëèíà), íàïðàâëåííàÿ, ïðåæäå âñåãî ïðîòèâ äâóõ ãðàìïîëîæèòåëüíûõ áàêòåðèé – Streptomyces aureus è Mycobacterium tuberculosis.


Íàñ÷åò ëå÷åíèÿ ÿ, âîîáùå-òî íå â òåìå, íî âîò ïîëþáîïûòñòâîâàë â "The Clinical Practice of Emergency Medicine 3rd edition (January 15, 2001)" :

The goal of therapeutic intervention in acute sinusitis is threefold: to relieve obstruction of the OMC, to restore mucociliary clearance, and to reestablish sinus sterility through eradication of infection.9 As acute sinusitis is not purely an infectious process, antimicrobial therapy alone will likely fail.11 Combination treatment with antibiotics, topical steroids, nasal decongestants, mucoevacuants, anticholinergics, antihistamines, and nonpharmacologic measures may provide the best symptomatic and therapeutic outcome.
Antibiotics have been the mainstay of treatment for acute sinusitis, but great controversy exists regarding indications for use, choice of antimicrobial agent, and duration of therapy. Mild cases of rhinosinusitis with symptoms lasting less than 7 days are most likely viral in etiology, and the temptation to prescribe antibiotics for these patients should be resisted.2,20 The natural course of untreated acute sinusitis is unknown, but it is estimated that 40% to 50% of cases would resolve spontaneously.7,16 Antimicrobial therapy is often cited as necessary to avoid development of complications of acute sinus disease; however, there is no prospective evidence to support this conclusion.
In patients meeting the diagnostic criteria for sinusitis with progressive or nonresolving symptoms for more than 7 days, use of a first-line antimicrobial agent is appropriate.2 Table 21.2 lists the commonly used first- and second-line antimicrobials for acute sinusitis. Amoxicillin is still highly effective and is the first-line agent of choice in acute sinusitis.7,20 Newer, more expensive antibiotics do not appear to be more effective than amoxicillin or trimethoprim plus sulfamethoxazole (TMP-SMX) in patients with uncomplicated sinusitis.3,20 Most studies suggest that almost any antibiotic results in clinical improvement greater than 85% of the time.16 Although no prospective study has established the optimum duration of therapy, a 10- to 14-day course is generally accepted as adequate.8,11 A small number of studies have shown 3 days of therapy as equally effective, but this is not yet an accepted practice.15 Second-line agents should be initiated if there is progression of symptoms after 2 to 3 days of initial therapy.2,7





TABLE 21.2. Antibiotic Therapy Alternatives in Acute Sinusitis16


The use of topical steroids in acute sinusitis is attractive, as they are potent antiinflammatories with few side effects. Studies have demonstrated improved symptom relief, but the clinical efficacy of topical steroids is uncertain.1,5 Steroids are generally well tolerated, with local irritation and bleeding as the most common side effects.5
Topical alpha-adrenergic agonists, such as oxymetolazone, have been used to decrease mucosal edema, promoting sinus drainage and ventilation. These agents should not be used for more than 3 days, as this may elicit rhinitis medicamentosa due to rebound vasodilation. Oral systemic decongestants (ephedrine, pseudoephedrine, phenylephrine, phenylpropanolamine, etc.) also can be taken, but side effects, including nervousness, insomnia, hypertension, and tachycardia, may limit their use. Despite the extensive use of these agents, their efficacy remains unclear.10
The mucoevacuant guaifenesin can be used to increase mucous flow and decrease mucous viscosity.1 Side effects are minimal but may include abdominal discomfort and emesis.5
Topical anticholinergics such as ipratropium bromide may reduce rhinorrhea, and thus can also be used as adjunctive therapy.1 Antihistamine use in acute sinusitis remains controversial. While antihistamines may decrease rhinorrhea, some argue that their use is contraindicated, as they increase mucous viscosity, leading to inspissation and outflow obstruction.8 Nonpharmacologic therapy such as steam inhalation and saline douching provide symptomatic relief by softening crusts and moisturizing dry mucosa.
All of these adjunctive therapies are based largely on anecdote and personal preference, as there is little evidence that these additions make a great impact on clinical outcome.8,10 It is likely that the longer acute sinusitis is treated, the more the natural course of infection is seen; that is, spontaneous resolution occurs regardless of what is done.11
Special consideration is needed for managing sinusitis in children, the elderly, and immunocompromised patients. Although debated, because children experience more URIs than do adults, the incidence of acute sinusitis in children may be higher. Sinusitis should be considered in any child with respiratory symptoms not improving after 10 days.8 Any child with recurrent acute sinusitis, or chronic sinusitis despite aggressive therapy, should be referred for evaluation for cystic fibrosis or underlying immune dysfunction.9,14 In elderly patients, the threshold to treat acute sinusitis should be lower, as aggressive medical intervention may be important in reducing morbidity in this group.5 In immunocompromised patients, increased alertness for fulminant sinusitis and its complications is necessary. Sinusitis is one of the most common problems affecting HIV-positive patients.18 The treatment of acute sinusitis is essentially the same regardless of HIV status, except for duration of antimicrobial therapy (21 days is standard).19 When CD4+ counts fall below 200, opportunistic sinus infections become more common and more resistant to standard therapy.18
Îòâåòèòü ñ öèòèðîâàíèåì
  #66  
Ñòàðûé 12.03.2005, 10:48
Íàòàëüÿ Ï. Íàòàëüÿ Ï. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 16.11.2004
Ãîðîä: íåò
Ñîîáùåíèé: 13,066
Ïîáëàãîäàðèëè 1,101 ðàç(à) çà 845 ñîîáùåíèé
Íàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåÍàòàëüÿ Ï. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìåäèêåí ïèøåò
"óìêàëîð - ïðîòèâîâèðóñíîå è àíòèáàêòåðèàëüíîå äåéñòâèå"

Âîò îïèñàíèå, ãäå òàì ïðîòèâîâèðóñíîå..
Ëàòèíñêîå íàçâàíèå: Umckalor®
Èçãîòîâèòåëü: Deutsche Homeopathie Union

Ñîñòàâ è ôîðìà âûïóñêà:
Êàïëè äëÿ ïðèåìà âíóòðü: 20 ìë è 50 ìë âî ôëàêîíå.
10 ã ýêñòðàêò êîðíåé Pelargonium sidoides 8 ã

Ôàðìàêîëîãè÷åñêîå äåéñòâèå:
Ïðåïàðàò ðàñòèòåëüíîãî ïðîèñõîæäåíèÿ. Îáëàäàåò ïðîòèâîìèêðîáíîé àêòèâíîñòüþ â îòíîøåíèè ñòàôèëîêîêêîâ è ñòðåïòîêîêêîâ.

Ïîêàçàíèÿ:
Îñòðûå è õðîíè÷åñêèå çàáîëåâàíèÿ äûõàòåëüíûõ ïóòåé è ËÎÐ-îðãàíîâ (ñèíóñèò, òîíçèëëÿðíàÿ àíãèíà, ðèíîôàðèíãèò, áðîíõèò).

Ðåæèì äîçèðîâàíèÿ:
Íàçíà÷àþò èíäèâèäóàëüíî. Ïðè îñòðûõ çàáîëåâàíèÿõ: âçðîñëûì — ïî 20-30 êàïåëü 3 ðàçà/ñóò, äàëåå, îñîáåííî ïðè õðîíè÷åñêîì òå÷åíèè çàáîëåâàíèÿ èëè ÷àñòûõ ðåöèäèâàõ, — ïî 10-20 êàïåëü 3 ðàçà/ñóò. Äåòÿì îò 6 äî 12 ëåò ïðè îñòðûõ èíôåêöèÿõ — ïî 10-20 êàïåëü 3 ðàçà/ñóò. Äåòÿì äî 6 ëåò — ïî 5-10 êàïåëü (â çàâèñèìîñòè îò âîçðàñòà) 3 ðàçà/ñóò. Êàïëè ïðèíèìàþò äî åäû ñ íåáîëüøèì êîëè÷åñòâîì æèäêîñòè.

Ïîáî÷íîå äåéñòâèå:
 íàñòîÿùåå âðåìÿ íå âûÿâëåíî.

Ïðîòèâîïîêàçàíèÿ:
Áåðåìåííîñòü, ïåðèîä ëàêòàöèè, ñêëîííîñòü ê êðîâîòå÷åíèÿì, âûðàæåííûå íàðóøåíèÿ ôóíêöèè ïå÷åíè è ïî÷åê.

Îñîáûå óêàçàíèÿ:
Áëàãîäàðÿ ñâîåé õîðîøåé ïåðåíîñèìîñòè, óìêàëîð îñîáåííî ïîêàçàí äëÿ ëå÷åíèÿ äåòåé (â òîì ÷èñëå äåòåé ìëàäøåãî âîçðàñòà). Äëÿ ïðîôèëàêòèêè ðåöèäèâîâ ðåêîìåíäóåòñÿ ïðîäîëæàòü ëå÷åíèå ïðåïàðàòîì â òå÷åíèå íåñêîëüêèõ äíåé ïîñëå èñ÷åçíîâåíèÿ ñèìïòîìîâ çàáîëåâàíèÿ. Ïðè îäíîâðåìåííîì ïðèìåíåíèè ïðîèçâîäíûõ êóìàðèíà âîçìîæíî óñèëåíèå ïðîòèâîñâåðòûâàþùåãî ýôôåêòà êðîâè. Ïðåïàðàò ñîäåðæèò ýòèëîâûé ñïèðò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #67  
Ñòàðûé 12.03.2005, 10:51
Àâàòàð äëÿ Viktor Leboev
Viktor Leboev Viktor Leboev âíå ôîðóìà
Ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 31.01.2004
Ñîîáùåíèé: 191
Viktor Leboev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåViktor Leboev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåViktor Leboev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåViktor Leboev ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Dr.
Öèòàòà:
1,44 ã êîôåéíîé êèñëîòû ñîîòâåòñòâóåò 1 åäèíèöà ïåíèöèëëèíà
 ïåðåñ÷òå íà 1ìëí. Ýòî áóäåò 1,44 òîííû...
Ñóòî÷íóþ äîçó äàæå ñ÷èòàòü áîþñü


.
Îòâåòèòü ñ öèòèðîâàíèåì
  #68  
Ñòàðûé 12.03.2005, 16:10
Àâàòàð äëÿ MedicKen
MedicKen MedicKen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.03.2005
Ãîðîä: ÐÔ, Êðûì
Ñîîáùåíèé: 473
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
MedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàòàëüÿ Ï. Äàþ ññûëêè íà ïðîòèâîâèðóñíîå äåéñòâèå:

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
"îñîáîå âíèìàíèå ïðèâëåêàåò ôèòîàíòèáèîòèê ñ ïðîòèâîâèðóñíûì è èììóíîìîäóëèðóþùèì äåéñòâèåì Óìêàëîð, êîòîðûé ïðè äîñòàòî÷íî âûñîêîé êëèíè÷åñêîé ýôôåêòèâíîñòè ëèøåí ïîáî÷íûõ ýôôåêòîâ, õàðàêòåðíûõ äëÿ ñèíòåòè÷åñêèõ àíòèáèîòèêîâ"
"Óìêàëîð ïðåïÿòñòâóåò ïðèêðåïëåíèþ âèðóñîâ ê ñòåíêàì êëåòîê ñëèçèñòîé îáîëî÷êè è ñòèìóëèðóåò ýíäîãåííóþ ñèñòåìó ïðîòèâîâèðóñíîé çàùèòû "

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
"Ôèòîàíòèáèîòèê ÓÌÊÀËÎÐ îêàçûâàåò àíòèáàêòåðèàëüíîå (áàêòåðèîñòàòè÷åñêîå), èììóíîìîäóëèðóþùåå è îïîñðåäîâàííîå ïðîòèâîâèðóñíîå äåéñòâèå (Kolodziej H., Heger M., 2000)."

Âèêòîð Ëåáîåâ - äóìàþ ýòî ïðîñòî î÷åïÿòêà Òåêñò ñêîðåå âñåãî ïðîõîäèë ÷åðåç àâòîðîâ, ñåêðåòàðÿ, èçäàòåëüñòâî, âýá-ìàñòåðà è ò.ä. Ãäå-òî áûëà äîïóùåíà îøèáêà.

Dr. - íàñêîëüêî ÿ îðèåíòèðóþñü â àíãëèéñêîì ÿçûêå ÿ ïîíèìàþ ïðåäëîæåíèå òàê:
"Ëå÷åíèå êîìáèíàöèåé àíòèáèîòèêîâ, òîïè÷åñêèìè ñòåðîèäàìè, äåêîãíèñòàíòàìè, ìóêîëèòèêàìè, àíòèõîëèíåðãè÷åñêèìè, àíòèãèñòàìèíûìè, è íåôàðìàêîëîãè÷åñêèìè ìåðàìè îáåñïå÷èò ëó÷øèé ñèìïòîìàòè÷åñêèé è òåðàïåâòè÷åñêèé ðåçóëüòàò"

Ïî-ìîåìó ýòî ïî÷òè ïîëíûé äóáëÿæ ìîèõ òåðàïåâòè÷åñêèõ íàçíà÷åíèé.

Òîïè÷åñêèå ãëþêîêîðòèêîñòåðîèäû ïðè ñèíóñèòàõ - ýòî çàïàäíîå óâëå÷åíèå. Ñåé÷àñ ó íàñ òîæå ïðåäëàãàþò. Íî ÿ êàê-òî íàñòîðîæåííî ê ýòîìó îòíîøóñü. Íàïðèìåð, â÷åðà êî ìíå ïðèøëà ïàöèåíòêà - ïîëó÷àëà íàçîíåêñ (áèîäîñòóïíîñòü 0,01%) â íîñ ïî ïîâîäó àëëåðãè÷åñêîãî ðèíèòà - äàæå íà åãî ôîíå ðèíîñêîïè÷åñêè áûë î÷åâèäíûì ãíîéíûé ïðîöåññ â ïàðàíàçàëüíûõ ñèíóñàõ. Äà è ñòîèò íàçîíåêñ îêîëî 18$. Êñòàòè, åñòü ðàáîòû ïî Ôëèêñîíàçå - ïðèìåíÿþò äëÿ ëå÷åíèÿ àäåíîèäíûõ âåãåòàöèé - ïîëó÷àþò ýôôåêò.

Àíòèáèîòèêè ïðè ñèíóñèòàõ... Ñèíóñèò ñèíóñèòó ðîçíü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #69  
Ñòàðûé 12.03.2005, 16:24
Àâàòàð äëÿ Dr.
Dr. Dr. âíå ôîðóìà
Ïî÷åòíûé ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 29.07.2004
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 10,123
Ïîáëàãîäàðèëè 446 ðàç(à) çà 427 ñîîáùåíèé
Dr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr. ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò MedicKen
Âèêòîð Ëåáîåâ - äóìàþ ýòî ïðîñòî î÷åïÿòêà Òåêñò ñêîðåå âñåãî ïðîõîäèë ÷åðåç àâòîðîâ, ñåêðåòàðÿ, èçäàòåëüñòâî, âýá-ìàñòåðà è ò.ä. Ãäå-òî áûëà äîïóùåíà îøèáêà.
À î÷åíü àêòèâíûé â îòíîøåíèè ïàëî÷êè Êîõà ïåíèöèëëèí ýòî êòî ïðèïèñàë? Äàëüøå ÷èòàë ïî-äèàãîíàëè. ß äàæå íå çíàþ, êòî ýòî òîò ñóïåðïðîôåññîð, íî ïîñêîëüêó ñòîèò îí â ñïèñêå ïîñëåäíåì, ñêîðåå âñåãî è íå ÷èòàë ñåãî òðóäà. Åñëè áû îí åãî ÷èòàë - áûë áû ïåðâûì . Ìîæåò ïðàâäà âî âòîðîì ìåäå âñå íå òàê. Äà ÷òî òàì ãîâîðèòü - âîí ó ìåíÿ êíèæêà ãäå-òî âàëÿëàñü, "òðàâìû íîñà". 1995 ãîä. Îáåçáîëèâàíèå ñëèçèñòîé ÷åì òàì? Ïðàâèëüíî, ðàñòâîðîì êîêàèíà. Î÷åíü óâàæàåìûé ÷åëîâåê åå ïèñàë. È ïðàâäà, âðà÷ îí - ñóïåð ïðîñòî, áåç øóòîê. Íî ïëàãèàòîð.
Îòâåòèòü ñ öèòèðîâàíèåì
  #70  
Ñòàðûé 12.03.2005, 17:11
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,282
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,625 ðàç(à) çà 32,699 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàê äîëæíû áûòü íàïèñàíû ñòàòüè äëÿ âðà÷à ( îáçîðû, ðåêîìåíäàöèè, ëåêöèè)?
Äîëæåí áûòü óêàçàí óðîâåíü äîêàçàòåëüíîñòè òîãî èëè èíîãî óòâåðæäåíèÿ... Ïðàêòèêà æå îáû÷íî ïîäòâåðæäàåò, ÷òî òî, ÷òî ïðîõîäèò ÁÅÇ ëå÷åíèÿ, ïðîéäåò è íåñìîòðÿ íà ëå÷åíèå...
 ýòîì ïëàíå îñîáåííî õîðîøè ïîðîé ïåäèàòðèÿ è àêóøåðñòâî.. Äåòñòâî è áåðåìåííîñòü - îáû÷íûå ñâîéñòâà çäîðîâûõ äþäåé, è ìåëêèå îòêëîíåíèÿ îò èäåàëüíîé íîðìû íå ïðèâîäÿò, êàê ïðàâèëî, ê ñåðüåçíûìè ïðîáëåìàì.. òàê ÷òî ëå÷è- íå õî÷ó...À ñåðüåçíûå âèäíû ñðàçó- è íå ïîëèêëèíè÷åñêîå îíè äåëî ...Âåðîÿòíî, ïîýòîìó ïðîñüáû êðèòè÷íîãî îñìûñëåíèÿ íàçíà÷åíèé íå î÷åíü-òî ïðèâèâàþòñÿ íà ýòîé ïî÷âå..
À ïîðÿäîê àâòîðîâ òåïåðü â ìîäå çàðóáåæíûé ( â îòëè÷èå îò ïðèíöèïîâ evidence based medicine, ãäå ïðîãíèâøèé çàïàä íàì íå óêàç) ïîðÿäîê ìû óæå ïåðåíèìàåì- ðóêîâîäèòåëü - ïîñëåäíèé( ýòî åãî ëþäè äåëàëè).
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #71  
Ñòàðûé 12.03.2005, 17:16
Àâàòàð äëÿ MedicKen
MedicKen MedicKen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.03.2005
Ãîðîä: ÐÔ, Êðûì
Ñîîáùåíèé: 473
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
MedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Dr. - ïåðåâåë ïðèâåäåííóþ Âàìè ñòàòüþ.

Ìîæíî ïîëþáîïûòñòâîâàòü: à ïî÷åìó Âû òàê ëþáèòå è óâàæàåòå, ïðèñëóøèâàåòåñü ê àíãëîÿçû÷íûì èñòî÷íèêàì? Ó íàñ ñî ñïåöèàëèñòàìè è ãðàìîòíûìè ëþäüìè ïðîáëåìû?

Ðàçðåøèòå ïîäåëèòñÿ âïå÷àòëåíèÿìè ïî ñòàòüå.

"rhinosinusitis - äëèòåëüíîñòüþ äî 7 äíåé âèðóñíîé ýòèîëîãèè" - îá ýòîì ó íàñ äàâíî ãîâîðÿò. Íåò ðèíèòà áåç ñèíóñèòà... Ñîîòâåòñòâåííî ïðè ÎÐÂÈ ïàçóõè òîæå ñòðàäàþò. Åñòü àäåíîèäû èëè äðóãèå ïðåïÿòñòâèÿ íîðìàëüíîé àýðàöèè ïàçóõè, åñòü ñíèæåíèå èììóíèòåòà, ïðèñîåäèíåíèÿ âòîðè÷íîé èíôåêöèè - ïîëó÷àé ñèíóñèò. Åñòü õîðîøàÿ êíèãà Ïèñêóíîâà "Êëèíèíè÷åñêàÿ ðèíëîãèÿ" - çàìå÷àòåëüíî ïèøåò ïî ïàòîãåíåçó ñèíóñèòîâ.

"oxymetolazone íå äîëæíû èñïîëüçîâàòüñÿ â òå÷åíèå áîëüøå ÷åì 3 äíåé" - òîæå èçâåñòíî.

"èñïîëüçîâàíèå àíòèãèñòàìèííûõ â îñòðîì sinusitis îñòàåòñÿ ñïîðíûì"

"mucoevacuant guaifenesin ìîæåò èñïîëüçîâàòüñÿ, ÷òîáû óâåëè÷èòü ìóêîöèëèàðíûé êëèðåíñ è óìåíüøèòü âÿçêîñòü îòäåëÿåìîãî, ïîáî÷íûå ýôôåêòû ÿâëÿþòñÿ ìèíèìàëüíûìè, íî ìîæåò âûçûâàòü òîøíîòó è ðâîòó"

"Âñå ýòè äîáàâî÷íîå ëå÷åíèå áàçèðóþòñÿ â çíà÷èòåëüíîé ñòåïåíè íà ñïëåòíÿõ è ëè÷íîì ïðåäïî÷òåíèè, äàþò íå áîëüøîé êëèíè÷åñêèé ýôôåêò"

Õîðîøèé àâòîð, âñå ïðåïàðàòû ðàññìîòðåë, âî âñåõ ñîìíåâàåòñÿ, òî íå äîêàçàíî, ýòî ïîáî÷íûå ýôôåêòû ìîæåò âûçâàòü, à ýòî ñïîðíî.

Îñòàåòñÿ îäèí íåíàâÿç÷èâûé âîïðîñ, à êàê ëå÷èòü? Òðè äíÿ íàçíà÷èòü ñîñóäîñóæèâàþùèå, äî 7 äíåé òå÷åíèÿ çàáîëåâàíèÿ àíòèáèîòèêè íå ïðèìåíÿòü, íà 7 äåíü ìîæíî íàçíà÷èòü àìîêñèöèëèí. Âñå îñòàëüíûå ïðåïàðàòû - ýôôåêòèâíîñòü ñîìíèòåëüíà, ïîáî÷íûå ýôôåêòû. Õîòåë áû ÿ ïîñìîòðåòü íà ñåìåéíîãî âðà÷à, ïåäèàòðà, ËÎÐà, êîòîðûé ïðî÷èòàë ýòó ñòàòüþ è íàçíà÷àåò íà òðè äíÿ ñ ïîäòâåðæäåííûì ïî ñíèìêó ãàéìîðîýòìîèäèòîì ñ òîòàëüíûì çàòåìíåíèåì ïàçóõ îêñèìåòàçîëèí â íîñ, îáèëüíîå ïèòüå, ïîñòåëüíûé ðåæèì, ðåêîìåíäóåò ïðèéòè ÷åðåç 7 äíåé è åñëè íå ïîìîæåò - íàçíà÷èò ôëåìîêñèí ñîëþòàá. ß óòðèðóþ êîíå÷íî. Íî êàêîâî?
Îòâåòèòü ñ öèòèðîâàíèåì
  #72  
Ñòàðûé 12.03.2005, 17:34
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,282
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,625 ðàç(à) çà 32,699 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
"à ïî÷åìó Âû òàê ëþáèòå è óâàæàåòå, ïðèñëóøèâàåòåñü ê àíãëîÿçû÷íûì èñòî÷íèêàì? Ó íàñ ñî ñïåöèàëèñòàìè è ãðàìîòíûìè ëþäüìè ïðîáëåìû?"
-
íåò, ïðîñòî âñåãäà ëþáîïûòíî çíàòü, êàê æå âûæèâàþò ëþäè, ëèøåííûå âîçìîæíîñòè ïîðîé îáùàòüñÿ ñ íàøèìè ñïåöèàëèñòàìè, íî ïðè ýòîì æèâóùèå íà 20 ëåò äîëüøå è ñ êóäà áîëåå íèçêîé äåòñêîé ñìåðòíîñòüþ..
Êðîìå òîãî, ïîðàæàåò, ÷òî ýòè ñàìûå ëþäè ñòðåìÿòüñÿ ëå÷èòü íå ïî ìíåíèþ îäíîãî âåëèêîãî ÷åëîâåêà, à ñîáèðàþòñÿ, ðàçðàáàòûâàþò ñòðàòåãè÷åñêèå íàïðàâëåíèÿ( ãàéäëàéíû), ñîãëàñîâûâàþò ïðàâèëà ( êîíñåíñóñû), è îáÿçàòåëüíî ñêóðïóëåçíî óêàçûâàþò- êàê è êàêèì ìåòîäîì ïîëó÷åíî òî èëè èíîå óòâåðæäåíèå...
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #73  
Ñòàðûé 12.03.2005, 17:41
Àâàòàð äëÿ MedicKen
MedicKen MedicKen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.03.2005
Ãîðîä: ÐÔ, Êðûì
Ñîîáùåíèé: 473
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
MedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Melnichenko "Ïðàêòèêà æå îáû÷íî ïîäòâåðæäàåò, ÷òî òî, ÷òî ïðîõîäèò ÁÅÇ ëå÷åíèÿ, ïðîéäåò è íåñìîòðÿ íà ëå÷åíèå..."

Ñîãëàñåí. ß óæå ãîâîðèë, ÷òî ïî ìíåíèþ ìíîãèõ àâòîðîâ ïàçóõè âñåãäà âîâëåêàþòñÿ â ïðîöåññ ïðè ÎÐÂÈ. Ïðîöåññ íå ïðîõîäèò ñàìîñòîÿòåëüíî, åñëè åñòü "ôàêòîðû ðèñêà" - íàðóøåíèèÿ àðõèòåêòîíèêè ïîëîñòè íîñà, àäåíîèäíûå âåãåòàöèè, ñíèæåíèå èììóíîëîãè÷åñêîé ðåçèñòåíòíîñòè.

Ìîæåò ÿ â íà÷àëå íå ñîâñåì ÿñíî âûðàæàëñÿ, íî ñðàçó ïðî÷èòàâ æàëîáû îòöà ðåáåíêà ÿ ñðàçó ïðåäñòàâèë ñåáå îïðåäåëåííóþ êàðòèíó - âÿçêèé ñåêðåò â êëåòêàõ ðåøåò÷àòîãî ëàáèðèíòà è ïîëîñòè íîñà, êîòîðûé ñ òðóäîì îòñìàðêèâàåò ðåáåíîê äàæå ïîñëå ñîñóäîñóæèâàþùèõ. Òàê ÷òî ÿ íå ñîáèðàëñÿ çàíèìàòñÿ ïîëèïðàãìàçèåé ÎÐÂÈ, öåëü áûëà èíàÿ - ëå÷èòü ýòìîèäèò. (ìîæåò è â íîñîãëîòêå íå âñå áëàãîïîëó÷íî áûëî) Leopold - ýòî ÿ íå î Âàøåì ðåáåíêå, ïðîñòî ïðèâåë òèïè÷íûé ïðèìåð áîëüíîãî...

Melnichenko "À ñåðüåçíûå âèäíû ñðàçó- è íå ïîëèêëèíè÷åñêîå îíè äåëî ..." - åñëè óæå ãîâîðèòü î çàïàäíîì îáðàçöå çäðàâîîõðàíåíèÿ, òî: íàñêîëüêî ìíå èçâåñòíî (ìîæåò ÿ îøèáàþñü) ñòàöèîíàðíàÿ ïîìîùü ñîñòàâëÿåò ãîðàçäî ìåíüøèé ïðîöåíò ÷åì ó íàñ, óïîð äåëàåòñÿ íà ïîëèêëèíè÷åñêîå çâåíî, ÷àñòíûé ïðèåì, ñåìåéíîãî âðà÷à, êîòîðûå ðåøàþò î÷åíü ìíîãî ïðîáëåì. Åñëè çàäàòüñÿ ïåðåôðàçèðîâàòü Âàøè ñëîâà (ïðè îïðåäåëåííîé äîëè ñêåïòèöèçìà), ïîëó÷àåòñÿ ÷òî - ñòàöèîíàðíàÿ ïîìîùü äåéñòâåííà, à âñå îñòàëüíîå ñàìî ïðîéäåò. ß óòðèðóþ è ïðåóâåëè÷èâàþ (íå çíàþ êàê óæ ñëîâà ïîäáèðàòü, ÷òîáû ìåíÿ íå îáâèíèëè â íåóâàæåíèè ê äîêòîðó ìåäèöèíñêèõ íàóê) êîíå÷íî, íî âñå æå....
Îòâåòèòü ñ öèòèðîâàíèåì
  #74  
Ñòàðûé 12.03.2005, 17:43
Àâàòàð äëÿ MedicKen
MedicKen MedicKen âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 07.03.2005
Ãîðîä: ÐÔ, Êðûì
Ñîîáùåíèé: 473
Ñêàçàë(à) ñïàñèáî: 19
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
MedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMedicKen ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ã.À. Ìåëüíè÷åíêî - èçâèíèòå íå óñïåâàþ íàáèðàòü ñîîáùåíèÿ - ïîýòîìó ïèøó èõ íå óñïåâ ïðî÷èòàòü ïîñëåäíåãî
Îòâåòèòü ñ öèòèðîâàíèåì
  #75  
Ñòàðûé 12.03.2005, 17:44
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò MedicKen
... ß âîçäåéñòâóþ íà âñå çâåíüÿ ïàòîãåíåçà :
Êëþ÷åâàÿ ôðàçà. Îêàçàëîñü, ÷òî ýòî âî ìíîãèõ ñëó÷àÿõ ñîâñåì íå íóæíî.
Âîò ïîñëåäíèå ðåêîìåíäàöèè ïî îòèòó (âðÿä ëè ïðîïëà÷åííûå ïðîèçâîäèòåëÿìè àíòèáèîòèêîâ, òàê êàê âî ìíîãèõ ñëó÷àÿõ íè÷åãî êðîìå îáåçáîëèâàíèÿ íå ðåêîìåíäóåòñÿ): [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 19:46.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.